Fludarabine Monophosphate in Refractory B-Chronic Lymphocytic Leukemia: Maintenance may be Significant to Sustain Response
Maria A. Angelopoulou(Laiko General Hospital of Athens), Gerassimos A. Pangalis(Athens Medical Center), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Christos Poziopoulos, Flora N. Kontopidou(Laiko General Hospital of Athens)
Cited by 17
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
|Science|1993|914
The complex role of tumor-infiltrating macrophages
|Nature Immunology|2022|859